Cheng Liu

Chief Executive Officer at ESTRELLA IMMUNOPHARMA, INC.

Net worth: 2 M $ as of 2026-05-30

60 year

5 connections

Health Technology

Consumer Services

Commercial Services

Profile

Cheng Liu is the founder of Eureka Therapeutics, Inc., founded in 2006, serving as President, Chief Executive Officer & Director.
Dr. Liu is also the founder of InvisiShield Technologies Ltd.,Estrella Biopharma, Inc...- Dr. Liu is currently President, Chief Executive Officer & Director at Estrella Immunopharma, Inc. since 2024.
Former positions include Chairman at JW (Cayman) Therapeutics Co. Ltd. from 2025 to 2026, Principal Scientist at Chiron Corp., and Member-Adversary & Executive Committee at SAPA-West from 1998 to 2007.
Education includes undergraduate and graduate degrees from Peking University and a doctorate from the University of California, Berkeley.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
JW (CAYMAN) THERAPEUTICS CO. LTD. 1.38%	2024-12-30	5,764,582 ( 1.38% )	1 M $	2026-05-30
ESTRELLA IMMUNOPHARMA, INC. 0.69%	2026-05-19	297,437 ( 0.69% )	324 206 $	2026-05-30

Cheng Liu active positions

Companies	Position	Start
ESTRELLA IMMUNOPHARMA, INC.	Chief Executive Officer	-
Eureka Therapeutics, Inc. Eureka Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors	Founder	2010-01-20
InvisiShield Technologies Ltd. InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Chief Executive Officer	-
Estrella Biopharma, Inc. Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces medicines for hematological cancers & tumors	Founder	-

All active positions of Cheng Liu

Former positions of Cheng Liu

Companies	Position	End
JW (CAYMAN) THERAPEUTICS CO. LTD	Chairman	2026-06-25
SAPA-West	Corporate Officer/Principal	2006-12-31
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Corporate Officer/Principal	-

See the detail of Cheng Liu's experience

Training of Cheng Liu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cheng Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Eureka Therapeutics, Inc. Eureka Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors	Health Technology
Peking University Peking University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SAPA-West
JW (Cayman) Therapeutics Co. Ltd. JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products	Health Technology
InvisiShield Technologies Ltd. InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Commercial Services
Estrella Biopharma, Inc. Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces medicines for hematological cancers & tumors	Health Technology
Estrella Immunopharma, Inc. Estrella Immunopharma, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biopharmaceutical company focusing on cancer therapeutics to address treatment of blood cancers and solid tumors	Health Technology